# Synexus Clinical Research Topco (Synexus Clinical Research Topco Limited) Private limited company registered in Cambridge, classed under “Other professional, scientific and technical activities n.e.c.”. - Company number: 09388942 - Status: Active - Type: Private limited company - Incorporated: 14 January 2015 - Registered office: 12b Granta Park, Great Abington, Cambridge, CB21 6GQ - Location: Cambridge - Activity: Other professional, scientific and technical activities n.e.c. ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Synexus Clinical Research Topco do? Private limited company registered in Cambridge, classed under “Other professional, scientific and technical activities n.e.c.”. ### How much turnover does Synexus Clinical Research Topco make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/synexus-clinical-research-topco-09388942 ### Is Synexus Clinical Research Topco profitable? Synexus Clinical Research Topco's profit isn't public: small companies may file without a profit and loss account. ### Who runs and owns Synexus Clinical Research Topco? Its directors are Oakwood Corporate Secretary Limited, Syed Waqas Ahmed, Euan Daney Ross Cameron, Georgina Adams Green, Anthony Hugh Smith and 1 more. Its owners are shown to subscribers. ### Where is Synexus Clinical Research Topco based? Its registered office is 12b Granta Park, Great Abington, Cambridge, CB21 6GQ, in Cambridge. ### When was Synexus Clinical Research Topco founded? Synexus Clinical Research Topco Limited was incorporated on 14 January 2015. ### Is Synexus Clinical Research Topco still trading? The register lists Synexus Clinical Research Topco Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-06-25: Full accounts made up to 31 December 2025 - 2026-04-01: Termination of appointment of Rhona Gregg as a secretary on 31 March 2026 - 2026-01-23: Cessation of Wildcat Acquisition Holdings (Uk) Limited as a person with significant control on 10 December 2024 - 2026-01-23: Notification of Thermo Fisher Scientific Inc. as a person with significant control on 10 December 2024 - 2025-07-07: Full accounts made up to 31 December 2024 - 2024-09-04: Statement of capital on 4 September 2024 · GBP 113,888.555 - 2024-09-04: Statement by Directors - 2024-09-04: Solvency Statement dated 03/09/24 - 2024-09-04: Resolutions (and 7 more like it since 13 March 2015) - 2024-09-04: Full accounts made up to 31 December 2023 - 2024-04-23: Appointment of Georgina Adams Green as a director on 18 April 2024 - 2024-04-19: Appointment of Alison Jane Starr as a director on 18 April 2024 - 2024-04-19: Termination of appointment of David John Norman as a director on 18 April 2024 - 2023-09-19: Statement of capital following an allotment of shares on 6 September 2023 · GBP 113,888.555 (and 10 more like it since 13 March 2015) - 2023-07-18: Full accounts made up to 31 December 2022 - 2023-05-25: Termination of appointment of Julia Mary James as a director on 24 May 2023 - 2023-04-06: Appointment of David John Norman as a director on 29 March 2023 - 2023-04-06: Termination of appointment of Richard Stuart Harris as a director on 29 March 2023 - 2023-04-06: Appointment of Syed Waqas Ahmed as a director on 29 March 2023 - 2023-04-06: Appointment of Euan Daney Ross Cameron as a director on 29 March 2023 - 2023-04-06: Appointment of Anthony Hugh Smith as a director on 29 March 2023 - 2022-11-30: Appointment of Oakwood Corporate Secretary Limited as a secretary on 29 November 2022 - 2022-11-30: Appointment of Rhona Gregg as a secretary on 29 November 2022 - 2022-09-14: Full accounts made up to 31 December 2021 - 2022-01-06: Register(s) moved to registered inspection location --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/synexus-clinical-research-topco-09388942